PT  - JOURNAL ARTICLE
AU  - Gavars, D.
AU  - Gavars, M.
AU  - Perminovs, D.
AU  - Stasulans, J.
AU  - Stana, J.
AU  - Metla, Z.
AU  - Pavare, J.
AU  - Tauckels, E.
AU  - Gulbis, E.
AU  - Dumpis, U.
TI  - Saliva as testing sample for SARS-CoV-2 detection by RT-PCR in low prevalence community setting
AID  - 10.1101/2020.10.20.20216127
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.20.20216127
4099  - http://medrxiv.org/content/early/2020/10/21/2020.10.20.20216127.short
4100  - http://medrxiv.org/content/early/2020/10/21/2020.10.20.20216127.full
AB  - The aim of our study was to demonstrate that saliva can be used as an effective material for SARS-CoV-2 testing and screening of large population groups to identify Covid-19 clusters.The most important aspect of saliva sampling approach is the convenience of obtaining material by self-sampling that is even possible at home.In our experiments, saliva was sufficiently stable for testing for at least 24 hours after collection.The results obtained from the saliva of a SARS-CoV-2 positive patient were consistent with those obtained from nasopharyngeal and oropharyngeal swabs from the same patient with the sensitivity 90% and specificity 100% during the first two weeks after the onset of symptoms.To demonstrate the usefulness of testing saliva material for mass screening, crowd sampling with pooling was performed on 3660 people in 3-day time (44 samples were tested positive).We conclude that saliva testing is an appropriate tool for screening campaigns and cluster detection, that is able to detect more infected people in a shorter period of time with little human resources and thus help to stop the epidemic spread more quickly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of Education and Science, Republic of Latvia. Funding number: VPP-COVID-2020/1-0008. Additional funding was provided by E.Gulbja laboratory.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by Ethics Committee of Pauls Stradins Clinical university hospital (record No 300720-18L).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analysed during this study are included in this published article.